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Heterogeneity of Acute Heart Transplant Rejection
Can Be Visualized by Cellular and Functional Cardiac
Magnetic Resonance*
Frederick H. Epstein, PHD
Charlottesville, VirginiaIn the paper by Wu et al. (1) in this issue of iJACC, a
novel, two-pronged cardiac magnetic resonance
(CMR) approach to imaging acute heart transplant
rejection was investigated. The two-pronged approach
employed both cellular and functional imaging to
examine an animal model of acute rejection. Cellular
CMR was performed by labeling macrophages using
an intravenous delivery of ultrasmall superparamag-
netic iron oxide (USPIO) particles and performing
imaging 1 day later to assess macrophage infiltration
of the myocardium, where labeled macrophages were
See page 731
seen as regions of reduced signal intensity. The
CMR tagging was used for simultaneous functional
assessment to quantify regional myocardial strain.
The methods were evaluated in rats, using an
allograft heterotopic working heart and lung model,
which undergoes rejection even as the native heart
maintains normal cardiac output. Images depicting
USPIO-labeled macrophages showed heteroge-
neous signal loss within the myocardium 1 day after
administration in allografts but not in isograft
controls. Similarly, myocardial tagging revealed
heterogeneous changes in myocardial strain in allo-
grafts but showed normal contraction throughout
the heart in isograft controls. As the grade of
rejection, determined by pathology, increased, the
sizes of the regions containing labeled macrophages
and the regions of decreased strain increased.
The primary contribution of the article by Wu et
al. (1) is the noninvasive in vivo demonstration of
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the University of Virginia Health System, Charlottesville, Virginia.
Dr. Epstein receives research support from Siemens Medical Solutions.the heterogeneity of acute allograft rejection, di-
rectly visualized by imaging both macrophage infil-
tration (Fig. 4 of Wu et al. [1]) as well as myocar-
dial strain (Fig. 5 of Wu et al. [1]). Even when large
regions of myocardium did not have evidence of
macrophage infiltration or contractile dysfunction,
other regions showed marked signal loss on T2*-
weighted images, indicating the presence of labeled
macrophages, and/or significant contractile dys-
function revealed by myocardial tagging. The het-
erogeneity of rejection was identified as a likely
explanation for why endomyocardial biopsy, the
standard clinical method for diagnosing acute rejec-
tion, can sometimes be inaccurate. Depending on
the particular locations that are sampled, biopsy
may or may not indicate rejection, even in the case of
severe rejection. Because imaging can cover the entire
heart without gaps, limited sampling is not a problem
for CMR-based assessment of transplant rejection.
A second important finding of the paper by Wu et
al. (1) is that, even though metrics describing global
cardiac function, such as stroke volume and ejection
fraction, do not discriminate between various grades of
acute rejection, the number of regions with compro-
mised strain increased as the grade of rejection in-
creased (Fig. 6 of Wu et al. [1]). In this context, the
investigators point out that because rejection does not
occur in the spatial regions defined by the coronary
territories, the interpretation of these images should
not be based on the conventional 17-segment model,
but rather using methods that are independent of the
coronary architecture. Interestingly, regions with re-
duced strain correlated with, but did not exactly
match, regions of macrophage infiltration. Further
work is required to more thoroughly elucidate the
relationship between macrophage infiltration and ab-
normal myocardial strain. Perhaps the 2 measure-
ments reflect different aspects of rejection or perhaps
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Editorial Comment
743here are temporal dependencies to macrophage infil-
ration and contractile dysfunction that are yet to be
xplored.
Whether macrophages are the ideal target for
ellular imaging of transplant rejection is an inter-
sting question. As Wu et al. (1) discuss, B and T
ymphocytes might be thought of as better targets
ue to their direct role in the rejection and inflam-
ation processes. However, macrophages are quite
asy to label in vivo using an intravenous injection
f USPIO particles, and they also play their own
mportant role in inflammation, so they certainly
re an attractive target. In addition, although it is
ommon to claim that intravenous injection of
SPIOs labels macrophages, it is possible that
ome other cell types may also take up USPIOs and
lso become labeled. In the future, it would be
nteresting to learn in more detail about the spec-
rum of cell labeling and detection in USPIO-
nhanced CMR of heart transplantation. Another
arget for molecular imaging of heart transplant
ejection is phosphatidylserine, which is a marker of
poptosis. Indeed, single-photon emission computed
omography imaging with technetium-99mm-labeled
nnexin-V, a protein that binds to phosphatidylserine
ith high affinity, has already shown promise for
etecting acute rejection in patients who have under-
one heart transplantation (2). Similar to the present
tudy by Wu et al. (1), single-photon emission com-
uted tomography imaging in hearts undergoing re-
ection also demonstrated spatially heterogeneous sig-
al intensity. Due to its higher spatial resolution,
MR may have an advantage compared with single-
hoton emission computed tomography for detecting
eterogeneous transplant rejection, as partial volume
ffects inherent with lower spatial resolution could
bscure focal regions of rejection.
Limitations of the present study include: 1) the
igh dose of USPIO; 2) use of T2*-weighted
maging instead of quantitative measurement of T2*Med 2001;7:1347–52, comment 1277–8. al. USPIO-enhancedransplantation (3) was not evaluated; and 4) that
he investigators did not use the tagged images to
nvestigate myocardial strain during diastole (4).
he USPIO dose appeared to be almost 10-fold
reater than a clinical dose of USPIO, although the
xact weights of the rats used in this study were not
rovided, making it difficult to accurately calculate
he dose. Thus, the question of whether clinical
oses will be similarly successful remains unan-
wered. The acquisition of quantitative T2* maps,
hough more time-consuming than T2*-weighted
mages, might be useful for making studies such as
his more reproducible by other labs. Also, as
peculated previously in a clinical study (3),
adolinium-enhanced CMR may be sensitive to
ecrosis found in transplant rejection. The evalua-
ion of gadolinium-enhanced CMR in this rat
odel might provide greater insight into the po-
ential of this method for detecting fibrosis in
ransplant rejection. In addition, myocardial strain
maging, which was used to assess systolic function,
ight detect reduced diastolic function, which may
e important in transplant rejection (4).
The methods used in the present study may be
pplied to human subjects after heart transplanta-
ion, perhaps in the near future. Indeed, the initial
valuation of USPIO-enhanced CMR for the as-
essment of kidney transplantation in humans has
ecently been published with encouraging prelimi-
ary results (5). It is a distinct possibility that the
etection of acute heart transplant rejection will
merge as one of the first important clinical appli-
ations of cell-labeled CMR.
eprint requests and correspondence: Dr. Frederick H.
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